Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Non-cash Items (2017 - 2018)

Denali Therapeutics (DNLI) has disclosed Non-cash Items for 2 consecutive years, with $1.5 million as the latest value for Q1 2018.

  • On a quarterly basis, Non-cash Items changed N/A to $1.5 million in Q1 2018 year-over-year; TTM through Mar 2018 was $1.5 million, a N/A change, with the full-year FY2017 number at $77.3 million, changed N/A from a year prior.
  • Non-cash Items was $1.5 million for Q1 2018 at Denali Therapeutics, down from $77.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $77.3 million in Q4 2017 to a low of $1.5 million in Q1 2018.